HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study
- 1 January 2018
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 536 (1) , 108-115
Abstract
No abstract availableKeywords
Funding Information
- Czech Science Foundation (15-02986S)
- Academy of Sciences of Czech Republic (JSPS-16-05)
- Ministry of Health, Labour and Welfare (MHLW), Japan for Cancer Specialty
- Matching Fund Subsidy for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MECSST)
- Biodynamic Research Foundation in Kumamoto, Japan
This publication has 33 references indexed in Scilit:
- Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?Journal of Drug Delivery, 2013
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Biodegradable star HPMA polymer–drug conjugates: Biodegradability, distribution and anti-tumor efficacyJournal of Controlled Release, 2011
- Tumor delivery of macromolecular drugs based on the EPR effectAdvanced Drug Delivery Reviews, 2011
- New Role for L-Arginine in Regulation of Inducible Nitric-Oxide-Synthase-Derived Superoxide Anion Production in Raw 264.7 MacrophagesThe Scientific World Journal, 2011
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal CancerNew England Journal of Medicine, 2009
- Macromolecular TherapeuticsClinical Pharmacokinetics, 2003
- SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapyAdvanced Drug Delivery Reviews, 1991
- Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding LigandJournal of Bioactive and Compatible Polymers, 1988